People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Veana Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $1.4M | $32.8M | 2020 |
| CytoImage Inc. | — | Biotechnology | Pre-Seed | $225K | $6.8M | 2021 |
Sandra Shotwell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sandra Shotwell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Trent D. Davis | 1 | 5 |
| Thomas E McChesney | 1 | 5 |
| Denis R. Burger | 1 | 3 |
| Andrew Ray | 1 | 3 |
| Ann Bunnenberg | 1 | 2 |
| BRUCE RAMSEYER | 1 | 1 |
| F Andrew Ray | 1 | 1 |
| Mark F Holifer | 1 | 1 |
| Rebecca F Akporiaye | 1 | 1 |
| Andrew D Thaler | 1 | 1 |
| Lynnor Stevenson | 1 | 1 |
| Tania Vu | 1 | 1 |
| EMMANUEL AKPORIAYE | 1 | 1 |
| REBECCA AKPORIAYE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.